AMIE COLLINS: Open Payments
NPI 1902845407 · SALISBURY, NC. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$616 in 27 payments from 11 companies in 2025. Trend: 2023 $734 · 2024 $537 · 2025 $616
Food & beverage: $616
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 9 | $206 |
| AstraZeneca Pharmaceuticals LP | 3 | $69 |
| PFIZER INC. | 4 | $68 |
| Dexcom, Inc. | 2 | $60 |
| ABBVIE INC. | 2 | $55 |
| Abbott Laboratories | 2 | $48 |
| Sumitomo Pharma America, Inc. | 1 | $29 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 1 | $27 |
| GlaxoSmithKline, LLC. | 1 | $18 |
| Bayer Healthcare Pharmaceuticals Inc. | 1 | $17 |
Products named: Wegovy, Dexcom G6 Transmitter, UBRELVY, PREVNAR 20, FREESTYLE LIBRE 3, AIRSUPRA, Rybelsus, GEMTESA.
Industry payments across NC — which companies pay providers there.
